Cynata Therapeutics Limited Stock Price Prediction
| CYYNF Stock | USD 0.19 0.00 0.00% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using Cynata Therapeutics hype-based prediction, you can estimate the value of Cynata Therapeutics Limited from the perspective of Cynata Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Cynata Therapeutics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Cynata because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cynata Therapeutics after-hype prediction price | USD 0.19 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cynata |
Cynata Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Cynata Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cynata Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Cynata Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cynata Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Cynata Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cynata Therapeutics' historical news coverage. Cynata Therapeutics' after-hype downside and upside margins for the prediction period are 0.19 and 0.19, respectively. We have considered Cynata Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cynata Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Cynata Therapeutics is based on 3 months time horizon.
Cynata Therapeutics Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Cynata Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cynata Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cynata Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 11 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.19 | 0.19 | 0.00 |
|
Cynata Therapeutics Hype Timeline
Cynata Therapeutics is currently traded for 0.19. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Cynata is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Cynata Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.19. About 15.0% of the company shares are held by company insiders. The book value of Cynata Therapeutics was currently reported as 0.17. The company recorded a loss per share of 0.02. Cynata Therapeutics had not issued any dividends in recent years. Assuming the 90 days horizon the next estimated press release will be in 5 to 10 days. Check out Cynata Therapeutics Basic Forecasting Models to cross-verify your projections.Cynata Therapeutics Related Hype Analysis
Having access to credible news sources related to Cynata Therapeutics' direct competition is more important than ever and may enhance your ability to predict Cynata Therapeutics' future price movements. Getting to know how Cynata Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cynata Therapeutics may potentially react to the hype associated with one of its peers.
Cynata Therapeutics Additional Predictive Modules
Most predictive techniques to examine Cynata price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cynata using various technical indicators. When you analyze Cynata charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cynata Therapeutics Predictive Indicators
The successful prediction of Cynata Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cynata Therapeutics Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cynata Therapeutics based on analysis of Cynata Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cynata Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cynata Therapeutics's related companies.
Story Coverage note for Cynata Therapeutics
The number of cover stories for Cynata Therapeutics depends on current market conditions and Cynata Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cynata Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cynata Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Cynata Therapeutics Short Properties
Cynata Therapeutics' future price predictability will typically decrease when Cynata Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cynata Therapeutics Limited often depends not only on the future outlook of the potential Cynata Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cynata Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 143.3 M |
Complementary Tools for Cynata Pink Sheet analysis
When running Cynata Therapeutics' price analysis, check to measure Cynata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cynata Therapeutics is operating at the current time. Most of Cynata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cynata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cynata Therapeutics' price. Additionally, you may evaluate how the addition of Cynata Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |